Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Newly Acquired Molecular Mutations and SNP-A Lesions Alters the Natural History of Trisomy 8 Myeloid Neoplasms

Yang Liu, BA, Paul Elson, ScD, Ali Tabarroki, MD, Valeria Visconte, PhD, Edy Hasrouni, Manoj Bupathi, MD, Betty K. Hamilton, MD, Fabiola Traina, MD, PhD, Hien K. Duong, MD, Heesun J. Rogers, MD, PhD, Yogen Saunthararajah, MD, Rami S. Komrokji, MD, Mikkael A. Sekeres, MD, MS, Ramon V Tiu, MD

Blood (2012) 120 (21): 312.

https://doi.org/10.1182/blood.V120.21.312.312

Published: 2012

Journal Articles

A Prognostic Scoring System for Unclassifiable MDS and MDS/MPN

Yang Liu, BA, Ali Tabarroki, MD, Valeria Visconte, PhD, Edy Hasrouni, Manoj Bupathi, MD, Betty K. Hamilton, MD, Fabiola Traina, MD, PhD, Hien K. Duong, MD, Heesun J. Rogers, MD, PhD, Yogen Saunthararajah, MD, Rami S. Komrokji, MD, Mikkael A. Sekeres, MD, MS, Ramon V. Tiu, MD

Blood (2012) 120 (21): 1701.

https://doi.org/10.1182/blood.V120.21.1701.1701

Published: 2012

Journal Articles

Pathway Analysis of Molecular Mutations Can Modify Morphologic, Cytogenetic and Prognostic Risk Stratification Schemes in Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes/Myeloproliferative Neoplasms (MDS/MPN), and Secondary Acute Myeloid Leukemia (AML)

Edy Hasrouni, Valeria Visconte, PhD, Ali Tabarroki, MD, Heesun J. Rogers, MD, PhD, Fabiola Traina, MD, PhD, Anna Jankowska, MSC, Yang Liu, Betty K. Hamilton, MD, Manoj Bupathi, MD, Hideki Makishima, MD, PhD, Andres Jerez, MD, PhD, Edward A. Copelan, MD, Anjali Advani, MD, Michael A McDevitt, MD, PhD, Matt Kalaycio, MD, Yogen Saunthararajah, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD, Ramon V. Tiu, MD

Blood (2012) 120 (21): 3791.

https://doi.org/10.1182/blood.V120.21.3791.3791

Published: 2012

Journal Articles

Molecular Mutations in U2AF1 Are Most Commonly Found in Del20q Myelodysplastic Syndromes but Do Not Lead to Poor Prognosis in This Karyotypic Subtype

Ali Tabarroki, MD, Li Zhang, PhD, Valeria Visconte, PhD, Manoj Bupathi, MD, Heesun J. Rogers, MD, PhD, Hideki Makishima, MD, PhD, Fabiola Traina, MD, PhD, Betty K. Hamilton, MD, Edy Hasrouni, Michael J. Clemente, Paula de Melo Campos, MD, Hien K. Duong, MD, Anjali Advani, MD, Mikkael A. Sekeres, MD, MS, Edward A. Copelan, MD, Ramon V. Tiu, MD

Blood (2012) 120 (21): 3804.

https://doi.org/10.1182/blood.V120.21.3804.3804

Published: 2012

Journal Articles

Biological Rationale for the Favorable Clinical Outcomes of Patients Carrying SF3B1 Mutations in Myelodysplastic Syndromes with Ring Sideroblasts

Blood (2012) 120 (21): 922.

https://doi.org/10.1182/blood.V120.21.922.922

Published: 2012

Journal Articles

Anemia Associated with Increased IL-6 and IL-8 Levels Predicts for Worse Progression-Free Survival in T-Cell and NK-Cell Large Granular Lymphocyte (LGL) Leukemia but Is Improved by Treatment with Cyclophosphamide

Craig A. Portell, MD, Valeria Visconte, PhD, Michael J. Clemente, Manuel G. Afable, II, MD, Ali Tabarroki, MD, Fabiola Traina, MD, PhD, Yang Liu, Betty K. Hamilton, MD, Andres Jarez, Manoj Bupathi, MD, Leonard J. Horwitz, MD, Alan E. Lichtin, MD, Anjali Advani, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD, Ramon V. Tiu, MD

Blood (2012) 120 (21): 1261.

https://doi.org/10.1182/blood.V120.21.1261.1261

Published: 2012

Journal Articles

SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes

Blood (2012) 120 (16): 3173–3186.

https://doi.org/10.1182/blood-2012-05-430876

Published: 2012

Includes: Supplemental data

Journal Articles

Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis

Hideki Makishima, Valeria Visconte, Hirotoshi Sakaguchi, Anna M. Jankowska, Sarah Abu Kar, Andres Jerez, Bartlomiej Przychodzen, Manoj Bupathi, Kathryn Guinta, Manuel G. Afable, Mikkael A. Sekeres, Richard A. Padgett, Ramon V. Tiu, Jaroslaw P. Maciejewski

Blood (2012) 119 (14): 3203–3210.

https://doi.org/10.1182/blood-2011-12-399774

Published: 2012

Includes: Supplemental data

Journal Articles

Higher Rates of AML Transformation and Poor Risk Cytogenetics in Patients with Low Average Albumin Levels Confers Poor Prognosis in Myelodysplastic Syndromes,

Manoj Bupathi, MD, Valeria Visconte, PhD, Fabiola Traina, MD, PhD, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD, Ramon V. Tiu, MD

Blood (2011) 118 (21): 3832.

https://doi.org/10.1182/blood.V118.21.3832.3832

Published: 2011

Journal Articles

Association of SF3B1 with Ring Sideroblasts in patients, In Vivo, and In Vitro models of Spliceosomal Dysfunction

Blood (2011) 118 (21): 457.

https://doi.org/10.1182/blood.V118.21.457.457

Published: 2011

Journal Articles

Acquired Erythrocytosis on Treatment with Infliximab for Ankylosing Spondylitis

Manoj Bupathi, MD, Maria Antonelli, MD, Paul Hergenroeder, MD, Muhammad Khan, MD

Blood (2010) 116 (21): 5142.

https://doi.org/10.1182/blood.V116.21.5142.5142

Published: 2010

NARROW

Newly Acquired Molecular Mutations and SNP-A Lesions Alters the Natural History of Trisomy 8 Myeloid Neoplasms

A Prognostic Scoring System for Unclassifiable MDS and MDS/MPN

Pathway Analysis of Molecular Mutations Can Modify Morphologic, Cytogenetic and Prognostic Risk Stratification Schemes in Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes/Myeloproliferative Neoplasms (MDS/MPN), and Secondary Acute Myeloid Leukemia (AML)

Molecular Mutations in U2AF1 Are Most Commonly Found in Del20q Myelodysplastic Syndromes but Do Not Lead to Poor Prognosis in This Karyotypic Subtype

Biological Rationale for the Favorable Clinical Outcomes of Patients Carrying SF3B1 Mutations in Myelodysplastic Syndromes with Ring Sideroblasts

Anemia Associated with Increased IL-6 and IL-8 Levels Predicts for Worse Progression-Free Survival in T-Cell and NK-Cell Large Granular Lymphocyte (LGL) Leukemia but Is Improved by Treatment with Cyclophosphamide

SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes

Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis

Higher Rates of AML Transformation and Poor Risk Cytogenetics in Patients with Low Average Albumin Levels Confers Poor Prognosis in Myelodysplastic Syndromes,

Association of SF3B1 with Ring Sideroblasts in patients, In Vivo, and In Vitro models of Spliceosomal Dysfunction

Acquired Erythrocytosis on Treatment with Infliximab for Ankylosing Spondylitis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only